FDA.reportPublic FDA data

mitapivat 20 MG Oral Tablet [Pyrukynd]

RxCUI
2594479
RxNorm name
mitapivat 20 MG Oral Tablet [Pyrukynd]
Display name
mitapivat 20 MG Oral Tablet [Pyrukynd]
Full name
mitapivat 20 MG Oral Tablet [Pyrukynd]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PYRUKYNDMITAPIVATAgios Pharmaceuticals, Inc.4ccee896-e313-4c6c-9674-b4746ada0a902026-06-30Warnings, Adverse reactionsExact identifier
rxcui: 2594479

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
4ccee896-e313-4c6c-9674-b4746ada0a90pyrukynd 20 MG Oral Tablet [PSN] · mitapivat 20 MG Oral Tablet [Pyrukynd] [SBD] · Pyrukynd 20 MG (as mitapivat sulfate 23.4 MG) Oral Tablet [SY] · Pyrukynd 20 MG Oral Tablet [SY]49These highlights do not include all the information needed to use PYRUKYND safely and effectively. See full prescribing information for PYRUKYND. PYRUKYND ® (mitapivat) tablets, for oral use Initial U.S. Approval: 202220260422